Stockreport

Novus Therapeutics to Present OP0201 Data at the 20th International Symposium on Recent Advances in Otitis Media

NOVUS THERAPEUTICS  (NVUS) 
US:NASDAQ Investor Relations: ir.novustherapeutics.com/news-releases
PDF IRVINE, Calif.--(BUSINESS WIRE)-- Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients w [Read more]